Wall Street Experts
ver. ZuMIgo(08/25)
Renovaro Biosciences Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -151
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
Rok finansowy |
2011 |
2012 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
inf% |
-100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
0.0% |
0.0% |
-inf% |
23.6% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
EBIT (mln) |
-0 |
-0 |
-2 |
-2 |
-2 |
-3 |
-11 |
-12 |
-23 |
-116 |
-39 |
-82 |
EBIT Δ r/r |
0.0% |
23.9% |
6449.2% |
-12.7% |
13.2% |
34.9% |
239.4% |
8.5% |
96.3% |
396.0% |
-66.8% |
111.7% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
-4959.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
EBITDA (mln) |
-0 |
-0 |
-2 |
-2 |
-2 |
-5 |
-18 |
-12 |
-23 |
-23 |
-19 |
-80 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
-4895.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Podatek (mln) |
0 |
0 |
-0 |
-0 |
-0 |
-0 |
0 |
0 |
-0 |
0 |
1 |
0 |
Zysk Netto (mln) |
-0 |
-0 |
-2 |
-2 |
-2 |
-6 |
-18 |
-11 |
-27 |
-113 |
-40 |
-81 |
Zysk netto Δ r/r |
0.0% |
25.5% |
6207.4% |
-26.8% |
23.5% |
194.6% |
185.4% |
-36.6% |
134.1% |
324.5% |
-65.0% |
103.2% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
-4057.2% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
EPS |
-0.0029 |
-0.0075 |
-0.32 |
-0.18 |
-0.17 |
-0.29 |
-0.48 |
-0.25 |
-0.57 |
-2.16 |
-0.71 |
-0.84 |
EPS (rozwodnione) |
-0.0029 |
-0.0075 |
-0.32 |
-0.18 |
-0.17 |
-0.29 |
-0.48 |
-0.25 |
-0.57 |
-2.16 |
-0.71 |
-0.84 |
Ilośc akcji (mln) |
10 |
5 |
8 |
10 |
12 |
22 |
38 |
46 |
47 |
53 |
56 |
96 |
Ważona ilośc akcji (mln) |
10 |
5 |
8 |
10 |
12 |
22 |
38 |
46 |
47 |
53 |
56 |
96 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |